Health Catalyst (HCAT) Competitors

Health Catalyst (NASDAQ:HCAT) and Docebo (NASDAQ:DCBO) are both small-cap computer software companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Which has preferable earnings and valuation, HCAT or DCBO?

Docebo has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$306.58M	0.68	-$69.50M	-$1.51	-1.96
Docebo	$216.93M	3.92	$26.74M	$0.69	42.88

Which has more risk and volatility, HCAT or DCBO?

Health Catalyst has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, Docebo has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500.

Do insiders & institutionals hold more shares of HCAT or DCBO?

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 53.2% of Docebo shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Do analysts prefer HCAT or DCBO?

Health Catalyst currently has a consensus price target of $4.73, suggesting a potential upside of 59.71%. Docebo has a consensus price target of $43.00, suggesting a potential upside of 45.34%. Given Health Catalyst's higher possible upside, equities analysts plainly believe Health Catalyst is more favorable than Docebo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.27
Docebo	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56

Does the media refer more to HCAT or DCBO?

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Health Catalyst's average media sentiment score of 1.69 beat Docebo's score of 1.43 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Docebo	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HCAT or DCBO more profitable?

Docebo has a net margin of 9.29% compared to Health Catalyst's net margin of -31.67%. Docebo's return on equity of 60.39% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-31.67%	-7.21%	-3.28%
Docebo	9.29%	60.39%	15.63%

Summary

Docebo beats Health Catalyst on 9 of the 15 factors compared between the two stocks.